Document resource
Given high rates of antimicrobial resistance,1 British, American and European IUSTI guidelines recommend that management of Mycoplasma genitalium (M. gen) be guided by testing for macrolide resistance.2–4 Guidelines also recommend against screening asymptomatic individuals.